Stay updated on Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial
Sign up to get notified when there's something new on the Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial page.

Latest updates to the Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
- Check18 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check25 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check32 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference2%
- Check61 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check75 days agoChange DetectedThe webpage has undergone significant content changes, including the removal of detailed information about colorectal cancer and the introduction of a new study focused on erythromycin as a treatment for Familial Adenomatous Polyposis (FAP). Additionally, the names of the study directors have been added.SummaryDifference42%
Stay in the know with updates to Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial page.